Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Diabetes

  • 1
    News

    Gut bacteria linked to cardiovascular, other health conditions

    August 31, 2020

    “Microbiota and their metabolites ... could serve as potential therapeutic targets for the maintenance of health and prevention and treatment of cardiovascular diseases.”

  • 1
    News

    DAPA-CKD: SGLT2 inhibitor benefit extends to chronic kidney disease without diabetes

    August 31, 2020

    DAPA-CKD showed that dapagliflozin helps patients with albuminuria and declining eGFR levels whether or not they have type 2 diabetes.

  • 1
    News

    EMPEROR-Reduced: Empagliflozin’s HFrEF benefit solidifies class effects

    August 30, 2020

    The 25% cut in primary endpoints among HFrEF patients on empagliflozin matched the benefit seen before from dapagliflozin in DAPA-HF.

  • News

    Does metformin reduce risk for death in COVID-19?

    August 14, 2020

    “It is still unclear whether metformin is truly a miracle drug or whether it is simply used more often among people who are healthier and who do not have contraindications to its use.”

  • News

    Guidance covers glycemia in dexamethasone-treated COVID-19 patients

    August 10, 2020

    The latest document from the COVID-19 response group of the Association of British Clinical Diabetologists is a response to the recent RECOVERY trial.

  • News

    COVID-19 taking financial toll on people in U.S. with diabetes

    August 3, 2020

    Unemployment and income loss caused by the pandemic are higher among those with diabetes than in the general U.S. population.

  • 1
    News

    Real-world data show SGLT2 inhibitors for diabetes triple DKA risk

    July 29, 2020

    The findings are based on the use of three different SGLT2 inhibitors in Canada and the United Kingdom.

  • 1
    News

    Cleaner data confirm severe COVID-19 link to diabetes, hypertension

    July 27, 2020

    Initial reports that tied more severe COVID-19 disease to diabetes or hypertension used confounded data, but more refined data show similar links.

  • News

    Guidance addresses elders with diabetes during COVID-19

    July 16, 2020

    Two geriatricians from the Joslin Diabetes Center offer advice for navigating the challenges associated with helping these vulnerable adults during the COVID-19 pandemic.

  • News

    Hyperglycemia predicts COVID-19 death even without diabetes

    July 13, 2020

    This finding came from a retrospective analysis of 605 patients with COVID-19 seen at two hospitals in Wuhan, China.

Previous1 … 4 5 6 7 8 … 14Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
fa-facebookfa-linkedinfa-instagramfa-youtube-playfa-commentfa-envelopefa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences